Sign In
Buy EXEL
$51.60
+3.06 (+6.30%)
At Close: Jun 03, 2026
3 Stocks to Buy for a Soft Landing, If There Is One
10:35am, Thursday, 15'th Aug 2024
Recent economic data is reigniting talk about a soft landing for the economy. That means that the Federal Reserve's monetary policy regarding interest rates is neither too restrictive nor too loose.
4 Best Defensive Stocks For A Potential Soft Landing (SA Quant)
12:45pm, Tuesday, 13'th Aug 2024
Investors are seeking stability amid the global market selloff in early August, sparked by weak jobs data and fears of an emergency interest rate cut by the Fed. Recession fears were ignited after the
EXEL or CSLLY: Which Is the Better Value Stock Right Now?
12:40pm, Tuesday, 13'th Aug 2024
Investors with an interest in Medical - Biomedical and Genetics stocks have likely encountered both Exelixis (EXEL) and CSL Limited Sponsored ADR (CSLLY). But which of these two stocks is more attract
Exelixis (EXEL) Gains 14.9% in a Week on Strong Q2 Results
10:45am, Tuesday, 13'th Aug 2024
Exelixis' (EXEL) shares rally following an impressive performance in the second quarter, buoyed by a surge in license revenues.
Investing in Exelixis (EXEL)? Don't Miss Assessing Its International Revenue Trends
10:21am, Monday, 12'th Aug 2024
Review Exelixis' (EXEL) international revenue performance and how it affects the predictions of financial analysts on Wall Street and the future prospects for the stock.
Exelixis: sNDA Cabometyx Expansion Could Provide Revenue Boost
04:04pm, Thursday, 08'th Aug 2024
Exelixis, Inc. has a PDUFA date of April 3, 2025, set to decide whether Cabometyx should be approved for the treatment of patients with advanced pancreatic neuroendocrine tumors. U.S. net product reve
Argonne's Autonomie Express tool simulates real-world vehicle traffic to predict large-scale energy impact
02:58pm, Wednesday, 07'th Aug 2024
LEMONT, Ill.--(BUSINESS WIRE)--The tool — free to all users — estimates energy consumption for a wide range of vehicles, both current and future.
Exelixis (EXEL) Q2 Earnings Beat, Milestone Payments Fuel Revenues
02:30pm, Wednesday, 07'th Aug 2024
Exelixis (EXEL) beats on earnings and sales in the second quarter. Its shares are trading up in response to the results.
Analyst Sees Exelixis At Inflection Point Despite Mixed Trial Results
02:15pm, Wednesday, 07'th Aug 2024
In its second-quarter earnings release, Exelixis, Inc. EXEL announced that the final overall survival (OS) analysis for the phase 3 CONTACT-02 trial has been completed.
Exelixis, Inc. (EXEL) Q2 2024 Earnings Call Transcript
09:30pm, Tuesday, 06'th Aug 2024
Exelixis, Inc. (NASDAQ:EXEL ) Q2 2024 Earnings Conference Call August 6, 2024 5:00 PM ET Company Participants Susan Hubbard - Executive Vice President, Public Affairs and Investor Relations Michael Mo
Exelixis (EXEL) Q2 Earnings: Taking a Look at Key Metrics Versus Estimates
07:36pm, Tuesday, 06'th Aug 2024
While the top- and bottom-line numbers for Exelixis (EXEL) give a sense of how the business performed in the quarter ended June 2024, it could be worth looking at how some of its key metrics compare t
Exelixis (EXEL) Tops Q2 Earnings and Revenue Estimates
06:37pm, Tuesday, 06'th Aug 2024
Exelixis (EXEL) came out with quarterly earnings of $0.84 per share, beating the Zacks Consensus Estimate of $0.37 per share. This compares to earnings of $0.31 per share a year ago.
What Analyst Projections for Key Metrics Reveal About Exelixis (EXEL) Q2 Earnings
10:21am, Monday, 05'th Aug 2024
Get a deeper insight into the potential performance of Exelixis (EXEL) for the quarter ended June 2024 by going beyond Wall Street's top -and-bottom-line estimates and examining the estimates for some
Exelixis (EXEL) Reports Next Week: Wall Street Expects Earnings Growth
11:06am, Tuesday, 30'th Jul 2024
Exelixis (EXEL) possesses the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.
Exelixis to Release Second Quarter 2024 Financial Results on Tuesday, August 6, 2024
04:05pm, Tuesday, 23'rd Jul 2024
ALAMEDA, Calif.--(BUSINESS WIRE)--Exelixis, Inc. (Nasdaq: EXEL) announced today that its second quarter 2024 financial results will be released on Tuesday, August 6, 2024 after the markets close. At 5
